{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:15:59Z","timestamp":1790741759707,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1008026","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000}}],"reference-count":89,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T00:00:00Z","timestamp":1568678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["1032144"],"award-info":[{"award-number":["1032144"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI100645"],"award-info":[{"award-number":["AI100645"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI145687"],"award-info":[{"award-number":["AI145687"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["Intramural"],"award-info":[{"award-number":["Intramural"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1008026","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T13:32:01Z","timestamp":1568727121000},"page":"e1008026","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":78,"title":["Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6653-6655","authenticated-orcid":true,"given":"Celia C.","family":"LaBranche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2065-3802","authenticated-orcid":true,"given":"Allen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8676-2345","authenticated-orcid":true,"given":"Shay","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9192-0440","authenticated-orcid":true,"given":"Xuejun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3935-4637","authenticated-orcid":true,"given":"Tongqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Wiehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7399-7954","authenticated-orcid":true,"given":"Kevin O.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Munir","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2973-2101","authenticated-orcid":true,"given":"Mattia","family":"Bonsignori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9159-1413","authenticated-orcid":true,"given":"Mario J.","family":"Borgnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7170-1937","authenticated-orcid":true,"given":"Quentin J.","family":"Sattentau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2468-8589","authenticated-orcid":true,"given":"Hongmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Xin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilton B.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lautaro G.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4446-1194","authenticated-orcid":true,"given":"Robert J.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1383-6865","authenticated-orcid":true,"given":"Thomas B.","family":"Kepler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bette T.","family":"Korber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Mascola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyamvada","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barton F.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0856-6319","authenticated-orcid":true,"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,9,17]]},"reference":[{"key":"ppat.1008026.ref001","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nri3516","article-title":"Broadly neutralizing antibodies and the search for an HIV\u20111 vaccine: the end of the beginning","volume":"9","author":"PD Kwong","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"ppat.1008026.ref002","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41590-018-0235-7","article-title":"Recent progress in broadly neutralizing antibodies to HIV","volume":"19","author":"D Sok","year":"2018","journal-title":"Nature Immunology"},{"key":"ppat.1008026.ref003","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nature01188","article-title":"HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites","volume":"420","author":"PD Kwong","year":"2002","journal-title":"Nature"},{"key":"ppat.1008026.ref004","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"X Wei","year":"2003","journal-title":"Nature"},{"key":"ppat.1008026.ref005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.aac5894","article-title":"Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen","volume":"349","author":"JG Jardine","year":"2015","journal-title":"Science"},{"key":"ppat.1008026.ref006","doi-asserted-by":"crossref","first-page":"10618","DOI":"10.1038\/ncomms10618","article-title":"Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice","volume":"7","author":"AT McGuire","year":"2016","journal-title":"Nat. Commun"},{"key":"ppat.1008026.ref007","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1126\/science.1111781","article-title":"Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies","volume":"308","author":"BF Haynes","year":"2005","journal-title":"Science"},{"key":"ppat.1008026.ref008","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1126\/science.1254990","article-title":"AIDS\/HIV. Host controls of HIV neutralizing antibodies","volume":"344","author":"BF Haynes","year":"2014","journal-title":"Science"},{"key":"ppat.1008026.ref009","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/imr.12508","article-title":"Host controls of HIV broadly neutralizing antibody development","volume":"275","author":"G Kelsoe","year":"2017","journal-title":"Immunological Reviews"},{"key":"ppat.1008026.ref010","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1241144","article-title":"Antibodies in HIV-1 vaccine development and therapy","volume":"341","author":"F Klein","year":"2013","journal-title":"Science"},{"key":"ppat.1008026.ref011","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.immuni.2012.08.012","article-title":"Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies","volume":"37","author":"PD Kwong","year":"2012","journal-title":"Immunity"},{"key":"ppat.1008026.ref012","first-page":"59","article-title":"HIV-1 neutralizing antibody signatures and application to epitope-targeted vaccine design. Cell Host &","volume":"25","author":"CA Bricault","year":"2019","journal-title":"Microbe"},{"key":"ppat.1008026.ref013","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.immuni.2017.05.007","article-title":"Elicitation of robust tier 2 neutralizing antibody responses in nonhuman primates by HIV envelope trimer immunization using optimized approaches","volume":"46","author":"M Pauthner","year":"2017","journal-title":"Immunity"},{"key":"ppat.1008026.ref014","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.celrep.2017.02.003","article-title":"Vaccine elicitation of high mannose-dependent neutralizing antibodies against the V3-glycan broadly neutralizing epitope in nonhuman primates","volume":"18","author":"KO Saunders","year":"2017","journal-title":"Cell Rep"},{"key":"ppat.1008026.ref015","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41591-018-0042-6","article-title":"Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1","volume":"6","author":"K Xu","year":"2018","journal-title":"Nat Med"},{"key":"ppat.1008026.ref016","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12517","article-title":"The quest for an antibody-based HIV vaccine","volume":"275","author":"BF Haynes","year":"2017","journal-title":"Immunol Rev"},{"key":"ppat.1008026.ref017","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.immuni.2018.04.029","article-title":"HIV-1 vaccines based on antibody identification, B cell ontogeny, and epitope structure","volume":"48","author":"PD Kwong","year":"2018","journal-title":"Immunity"},{"issue":"6133","key":"ppat.1008026.ref018","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1234150","article-title":"Rational HIV immunogen design to target specific germline B cell receptors","volume":"340","author":"J Jardine","year":"2013","journal-title":"Science"},{"issue":"4","key":"ppat.1008026.ref019","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.20122824","article-title":"Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies","volume":"210","author":"AT McGuire","year":"2013","journal-title":"The Journal of experimental medicine"},{"key":"ppat.1008026.ref020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.virol.2015.08.002","article-title":"Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers","volume":"486","author":"K Sliepen","year":"2015","journal-title":"Virology"},{"key":"ppat.1008026.ref021","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.it.2016.01.007","article-title":"HIV-1 envelope trimer design and immunization strategies to induce broadly neutralizing antibodies","volume":"37","author":"S.W. de Taeye","year":"2016","journal-title":"Trends in Immunology"},{"key":"ppat.1008026.ref022","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3389\/fimmu.2018.01116","article-title":"Cleavage-independent HIV-1 trimers from CHO cell lines elicit robust autologous tier 2 neutralizing antibodies","volume":"9","author":"S Bale","year":"2018","journal-title":"Front Immunol"},{"key":"ppat.1008026.ref023","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.cell.2015.11.056","article-title":"Immunogenicity of stabilized HIV-1 envelope trimers with reduced exposure of non-neutralizing epitopes","volume":"163","author":"SW de Taeye","year":"2015","journal-title":"Cell"},{"key":"ppat.1008026.ref024","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.celrep.2017.11.016","article-title":"Soluble prefusion closed DS-SOSIP.664-Env trimers of diverse HIV-1 strains","volume":"21","author":"MG Joyce","year":"2017","journal-title":"Cell Rep"},{"key":"ppat.1008026.ref025","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1084\/jem.20161160","article-title":"Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo","volume":"214","author":"M Medina\u2011Ram\u00edrez","year":"2017","journal-title":"J Exp Med"},{"issue":"9","key":"ppat.1008026.ref026","doi-asserted-by":"crossref","first-page":"e1003618","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"RW Sanders","year":"2013","journal-title":"PLoS Pathog"},{"key":"ppat.1008026.ref027","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.celrep.2017.07.077","article-title":"Improving the immunogenicity of native-like HIV-1 envelope trimers by hyperstabilization","volume":"20","author":"A Torrents de la Pe\u00f1a","year":"2017","journal-title":"Cell Rep"},{"key":"ppat.1008026.ref028","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1126\/science.1254426","article-title":"Conformational dynamics of single HIV-1 Env trimers on the surface of native virions","volume":"346","author":"JB Munro","year":"2014","journal-title":"Science"},{"issue":"11","key":"ppat.1008026.ref029","doi-asserted-by":"crossref","first-page":"e1007431","DOI":"10.1371\/journal.ppat.1007431","article-title":"HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies","volume":"14","author":"CC LaBranche","year":"2018","journal-title":"PLoS Pathog"},{"issue":"7446","key":"ppat.1008026.ref030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","volume":"496","author":"HX Liao","year":"2013","journal-title":"Nature"},{"issue":"2","key":"ppat.1008026.ref031","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cell.2016.02.022","article-title":"Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody","volume":"165","author":"M Bonsignori","year":"2016","journal-title":"Cell"},{"issue":"3","key":"ppat.1008026.ref032","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2014.06.022","article-title":"Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies","volume":"158","author":"F Gao","year":"2014","journal-title":"Cell"},{"key":"ppat.1008026.ref033","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.celrep.2017.04.013","article-title":"Quantification of the impact of the HIV-1-glycan shield on antibody elicitation","volume":"19","author":"T Zhou","year":"2017","journal-title":"Cell Rep"},{"issue":"5","key":"ppat.1008026.ref034","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2014.04.008","article-title":"Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers","volume":"40","author":"C Blattner","year":"2014","journal-title":"Immunity"},{"issue":"5","key":"ppat.1008026.ref035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2014.04.009","article-title":"Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers","volume":"40","author":"E Falkowska","year":"2014","journal-title":"Immunity"},{"issue":"21","key":"ppat.1008026.ref036","doi-asserted-by":"crossref","first-page":"13419","DOI":"10.1073\/pnas.212519299","article-title":"Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line","volume":"99","author":"PJ Reeves","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"ppat.1008026.ref037","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1128\/JVI.00105-10","article-title":"Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization","volume":"84","author":"JM Binley","year":"2010","journal-title":"Journal of virology"},{"issue":"5","key":"ppat.1008026.ref038","doi-asserted-by":"crossref","first-page":"e1007024","DOI":"10.1371\/journal.ppat.1007024","article-title":"Glycoengineering HIV-1 Env creates \u2018supercharged\u2019 and \u2018hybrid\u2019 glycans to increase neutralizing antibody potency, breadth and saturation","volume":"14","author":"ET Crooks","year":"2018","journal-title":"PLoS pathogens"},{"key":"ppat.1008026.ref039","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1126\/science.280.5371.1884","article-title":"The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens","volume":"280","author":"R Wyatt","year":"1998","journal-title":"Science"},{"key":"ppat.1008026.ref040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/COH.0000000000000442","article-title":"Neutralization tiers of HIV-1","volume":"13","author":"DC Montefiori","year":"2018","journal-title":"Curr Opin HIV AIDS"},{"key":"ppat.1008026.ref041","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.20130221","article-title":"Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies","volume":"210","author":"R Diskin","year":"2013","journal-title":"J Exp Med"},{"key":"ppat.1008026.ref042","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature11604","article-title":"HIV therapy by a combination of broadly neutralizing antibodies in humanized mice","volume":"492","author":"F Klein","year":"2012","journal-title":"Nature"},{"issue":"17","key":"ppat.1008026.ref043","doi-asserted-by":"crossref","first-page":"8954","DOI":"10.1128\/JVI.00754-11","article-title":"Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01","volume":"85","author":"Li Y","year":"2011","journal-title":"Journal of virology"},{"issue":"8","key":"ppat.1008026.ref044","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1128\/JVI.03608-14","article-title":"HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies","volume":"89","author":"RM Lynch","year":"2015","journal-title":"Journal of virology"},{"key":"ppat.1008026.ref045","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1016\/j.celrep.2017.12.028","article-title":"Vaccine induction of heterologous tier 2 HIV-1 neutralizing antibodies in animal models","volume":"21","author":"KO Saunders","year":"2017","journal-title":"Cell Rep"},{"key":"ppat.1008026.ref046","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.1192819","article-title":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01","volume":"329","author":"T Zhou","year":"2010","journal-title":"Science"},{"key":"ppat.1008026.ref047","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.immuni.2013.04.012","article-title":"Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies","volume":"39","author":"T Zhou","year":"2013","journal-title":"Immunity"},{"key":"ppat.1008026.ref048","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.cell.2015.05.007","article-title":"Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors","volume":"161","author":"T Zhou","year":"2015","journal-title":"Cell"},{"key":"ppat.1008026.ref049","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.1207532","article-title":"Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing","volume":"333","author":"X Wu","year":"2011","journal-title":"Science"},{"key":"ppat.1008026.ref050","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nsmb.3382","article-title":"Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer","volume":"24","author":"Q Liu","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"ppat.1008026.ref051","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nsmb.3144","article-title":"Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design","volume":"23","author":"J Gorman","year":"2016","journal-title":"Nat Struct Mol Biol"},{"issue":"11","key":"ppat.1008026.ref052","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.celrep.2016.02.058","article-title":"Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein","volume":"14","author":"AJ Behrens","year":"2016","journal-title":"Cell reports"},{"key":"ppat.1008026.ref053","doi-asserted-by":"crossref","first-page":"14954","DOI":"10.1038\/ncomms14954","article-title":"Global site-specific N-glycosylation analysis of HIV envelope glycoprotein","volume":"8","author":"L Cao","year":"2017","journal-title":"Nature communications"},{"key":"ppat.1008026.ref054","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"X Wu","year":"2010","journal-title":"Science"},{"key":"ppat.1008026.ref055","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1126\/science.aae0474","article-title":"Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody","volume":"352","author":"R Kong","year":"2016","journal-title":"Science"},{"issue":"7424","key":"ppat.1008026.ref056","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"J Huang","year":"2012","journal-title":"Nature"},{"issue":"5","key":"ppat.1008026.ref057","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.immuni.2016.10.027","article-title":"Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth","volume":"45","author":"J Huang","year":"2016","journal-title":"Immunity"},{"issue":"6049","key":"ppat.1008026.ref058","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"JF Scheid","year":"2011","journal-title":"Science"},{"issue":"47","key":"ppat.1008026.ref059","doi-asserted-by":"crossref","first-page":"E3268","DOI":"10.1073\/pnas.1217207109","article-title":"Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies","volume":"109","author":"H Mouquet","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"ppat.1008026.ref060","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1128\/JVI.07163-11","article-title":"Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design","volume":"86","author":"M Bonsignori","year":"2012","journal-title":"Journal of virology"},{"issue":"7","key":"ppat.1008026.ref061","doi-asserted-by":"crossref","first-page":"eaal2200","DOI":"10.1126\/sciimmunol.aal2200","article-title":"Potent and broad HIV-neutralizing antibodies in memory B cells and plasma","volume":"2","author":"LD Williams","year":"2017","journal-title":"Science Immunology"},{"issue":"1","key":"ppat.1008026.ref062","doi-asserted-by":"crossref","first-page":"e8805","DOI":"10.1371\/journal.pone.0008805","article-title":"Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals","volume":"5","author":"D Corti","year":"2010","journal-title":"PloS one"},{"issue":"5187","key":"ppat.1008026.ref063","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.7973652","article-title":"Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody","volume":"266","author":"DR Burton","year":"1994","journal-title":"Science"},{"issue":"49","key":"ppat.1008026.ref064","doi-asserted-by":"crossref","first-page":"17624","DOI":"10.1073\/pnas.1415789111","article-title":"Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex","volume":"111","author":"D Sok","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7365","key":"ppat.1008026.ref065","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"LM Walker","year":"2011","journal-title":"Nature"},{"key":"ppat.1008026.ref066","doi-asserted-by":"crossref","first-page":"9035","DOI":"10.1128\/JVI.76.18.9035-9045.2002","article-title":"Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize HIV-1 primary isolates from various clades","volume":"76","author":"MK Gorny","year":"2002","journal-title":"J Virol"},{"key":"ppat.1008026.ref067","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1128\/JVI.78.5.2394-2404.2004","article-title":"The V3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope","volume":"78","author":"MK Gorny","year":"2004","journal-title":"J Virol"},{"key":"ppat.1008026.ref068","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1128\/JVI.02202-05","article-title":"Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of HIV-1","volume":"80","author":"MK Gorny","year":"2006","journal-title":"J Virol"},{"key":"ppat.1008026.ref069","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molimm.2008.09.005","article-title":"Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1","volume":"46","author":"MK Gorny","year":"2009","journal-title":"Mol Immunol"},{"key":"ppat.1008026.ref070","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4049\/jimmunol.150.2.635","article-title":"Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120","volume":"150","author":"MK Gorny","year":"1993","journal-title":"J Immunol"},{"key":"ppat.1008026.ref071","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.4049\/jimmunol.159.10.5114","article-title":"Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity","volume":"159","author":"MK Gorny","year":"1997","journal-title":"J Immunol"},{"key":"ppat.1008026.ref072","doi-asserted-by":"crossref","first-page":"9384","DOI":"10.1128\/JVI.72.11.9384-9391.1998","article-title":"Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1","volume":"72","author":"PN Nyambi","year":"1998","journal-title":"J Virol"},{"key":"ppat.1008026.ref073","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0165-2478(01)00289-9","article-title":"Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120","volume":"79","author":"SA Jeffs","year":"2001","journal-title":"Immunol Lett"},{"key":"ppat.1008026.ref074","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1128\/JVI.69.6.3807-3815.1995","article-title":"Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry","volume":"69","author":"Zolla-Pazner S","year":"1995","journal-title":"J Virol"},{"key":"ppat.1008026.ref075","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.4049\/jimmunol.146.12.4325","article-title":"An IgG human monoclonal antibody that reacts with HIV-1\/gp120, inhibits virus binding to cells, and neutralizes infection","volume":"146","author":"MR Posner","year":"1991","journal-title":"J Immunol"},{"issue":"18","key":"ppat.1008026.ref076","doi-asserted-by":"crossref","first-page":"9286","DOI":"10.1128\/JVI.02286-10","article-title":"Epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individuals","volume":"85","author":"H Tang","year":"2011","journal-title":"Journal of virology"},{"key":"ppat.1008026.ref077","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-59745-170-3_26","article-title":"Measuring HIV neutralization in a luciferase reporter gene assay","volume":"485","author":"DC Montefiori","year":"2009","journal-title":"Methods in molecular biology"},{"issue":"2","key":"ppat.1008026.ref078","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virol.2010.02.019","article-title":"Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function","volume":"401","author":"D Eggink","year":"2010","journal-title":"Virology"},{"key":"ppat.1008026.ref079","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1128\/JVI.00718-12","article-title":"Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N\u2010terminal deletion","volume":"87","author":"SM Alam","year":"2013","journal-title":"J Virol"},{"key":"ppat.1008026.ref080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","article-title":"Gctf: Real-time CTF determination and correction","volume":"193","author":"K Zhang","year":"2016","journal-title":"J Struct Biol"},{"key":"ppat.1008026.ref081","doi-asserted-by":"crossref","first-page":"e42166","DOI":"10.7554\/eLife.42166","article-title":"New tools for automated high-resolution cryo-EM structure determination in RELION-3","author":"J Zivanov","year":"2018","journal-title":"Elife"},{"key":"ppat.1008026.ref082","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"A Punjani","year":"2017","journal-title":"Nat Methods"},{"key":"ppat.1008026.ref083","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"EF Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"ppat.1008026.ref084","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"P Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ppat.1008026.ref085","doi-asserted-by":"crossref","first-page":"e17219","DOI":"10.7554\/eLife.17219","article-title":"Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta","author":"RY Wang","year":"2016","journal-title":"Elife"},{"key":"ppat.1008026.ref086","first-page":"213","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"D66","author":"PD Adams","year":"2010","journal-title":"Acta Cryst"},{"issue":"Pt 1","key":"ppat.1008026.ref087","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"VB Chen","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ppat.1008026.ref088","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nmeth.3541","article-title":"EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy","volume":"12","author":"BA Barad","year":"2015","journal-title":"Nat Methods"},{"key":"ppat.1008026.ref089","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2105-5-69","article-title":"pdb-care (PDB CArbohydrate REsidue check): a program to support annotation of complex carbohydrate structures in PDB files","volume":"5","author":"T L\u00fctteke","year":"2004","journal-title":"BMC Bioinformatics"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1008200","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000}},{"DOI":"10.1371\/journal.ppat.1008026","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1008026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T08:11:21Z","timestamp":1695197481000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008026"}},"subtitle":[],"editor":[{"given":"David T.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,17]]},"references-count":89,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1008026","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,17]]}}}